| Product Code: ETC8271441 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Acute Myeloid Testing Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Acute Myeloid Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Acute Myeloid Testing Market - Industry Life Cycle |
3.4 Mexico Acute Myeloid Testing Market - Porter's Five Forces |
3.5 Mexico Acute Myeloid Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.6 Mexico Acute Myeloid Testing Market Revenues & Volume Share, By Product and Service, 2021 & 2031F |
3.7 Mexico Acute Myeloid Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Mexico Acute Myeloid Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mexico Acute Myeloid Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of acute myeloid leukemia (AML) in Mexico |
4.2.2 Growing awareness about the importance of early diagnosis and treatment |
4.2.3 Technological advancements in diagnostic testing for AML |
4.3 Market Restraints |
4.3.1 High cost associated with AML testing and treatment |
4.3.2 Limited access to advanced diagnostic facilities in certain regions of Mexico |
4.3.3 Regulatory challenges in approving new testing technologies |
5 Mexico Acute Myeloid Testing Market Trends |
6 Mexico Acute Myeloid Testing Market, By Types |
6.1 Mexico Acute Myeloid Testing Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Acute Myeloid Testing Market Revenues & Volume, By Biomarker Type, 2021- 2031F |
6.1.3 Mexico Acute Myeloid Testing Market Revenues & Volume, By Proteomic AML Biomarker, 2021- 2031F |
6.1.4 Mexico Acute Myeloid Testing Market Revenues & Volume, By Genetic AML Biomarker, 2021- 2031F |
6.1.5 Mexico Acute Myeloid Testing Market Revenues & Volume, By Epigenetic AML Biomarker, 2021- 2031F |
6.2 Mexico Acute Myeloid Testing Market, By Product and Service |
6.2.1 Overview and Analysis |
6.2.2 Mexico Acute Myeloid Testing Market Revenues & Volume, By Services, 2021- 2031F |
6.2.3 Mexico Acute Myeloid Testing Market Revenues & Volume, By Assay Kits, 2021- 2031F |
6.3 Mexico Acute Myeloid Testing Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Mexico Acute Myeloid Testing Market Revenues & Volume, By PCR, 2021- 2031F |
6.3.3 Mexico Acute Myeloid Testing Market Revenues & Volume, By IHC, 2021- 2031F |
6.3.4 Mexico Acute Myeloid Testing Market Revenues & Volume, By NGS, 2021- 2031F |
6.3.5 Mexico Acute Myeloid Testing Market Revenues & Volume, By Cytogenetics, 2021- 2031F |
6.3.6 Mexico Acute Myeloid Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Acute Myeloid Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Acute Myeloid Testing Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.3 Mexico Acute Myeloid Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Mexico Acute Myeloid Testing Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.4.5 Mexico Acute Myeloid Testing Market Revenues & Volume, By Cancer Diagnostic Institutes, 2021- 2031F |
7 Mexico Acute Myeloid Testing Market Import-Export Trade Statistics |
7.1 Mexico Acute Myeloid Testing Market Export to Major Countries |
7.2 Mexico Acute Myeloid Testing Market Imports from Major Countries |
8 Mexico Acute Myeloid Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of AML cases diagnosed annually |
8.2 Adoption rate of new AML testing technologies in Mexico |
8.3 Patient survival rates post-AML diagnosis |
8.4 Average turnaround time for AML test results |
8.5 Rate of reimbursement for AML diagnostic tests by healthcare insurers |
9 Mexico Acute Myeloid Testing Market - Opportunity Assessment |
9.1 Mexico Acute Myeloid Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.2 Mexico Acute Myeloid Testing Market Opportunity Assessment, By Product and Service, 2021 & 2031F |
9.3 Mexico Acute Myeloid Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Mexico Acute Myeloid Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mexico Acute Myeloid Testing Market - Competitive Landscape |
10.1 Mexico Acute Myeloid Testing Market Revenue Share, By Companies, 2024 |
10.2 Mexico Acute Myeloid Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here